μ-Opioid Receptor Agonists Differentially Regulate the Expression of miR-190 and NeuroD
- 23 October 2009
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET)
- Vol. 77 (1), 102-109
- https://doi.org/10.1124/mol.109.060848
Abstract
The agonists of μ-opioid receptor (OPRM1) induce extracellular signal-regulated kinase (ERK) phosphorylation through different pathways: morphine uses the protein kinase C (PKC)-pathway, whereas fentanyl functions in a β-arrestin2-dependent manner. In addition, the two pathways result in the different cellular location of phosphorylated ERK and the activation of different sets of transcriptional factors. In the current study, the influence of the two pathways on the expression of microRNAs (miRNAs) was investigated. After treating the primary culture of rat hippocampal neurons and the mouse hippocampi with morphine or fentanyl for 3 days, seven miRNAs regulated by one or two of the agonists were identified. One of the identified miRNAs, miR-190, was down-regulated by fentanyl but not by morphine. This down-regulation was attenuated by 1,4-diamino-2,3-dicyano-1,4-bis(methylthio)butadiene (U0126), which blocks the phosphorylation of ERK. When fentanyl-induced but not morphine-induced ERK phosphorylation was blocked in the primary cultures from β-arrestin2(−/−) mouse, fentanyl did not decrease the expression of miR-190. However, a PKC inhibitor that blocked morphine-induced ERK phosphorylation specifically had no effect on the miR-190 down-regulation. Therefore the decrease in miR-190 expression resulted from the agonist-selective ERK phosphorylation. In addition, the expressional changes in one of the miR-190 targets, neurogenic differentiation 1 (NeuroD), correlated with those in miR-190 expression, suggesting the OPRM1 could regulate the NeuroD pathways via the control of miR-190 expression.Keywords
This publication has 32 references indexed in Scilit:
- β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic ReceptorJournal of Biological Chemistry, 2006
- MicroRNAs: Genomics, Biogenesis, Mechanism, and FunctionCell, 2004
- The Role of BETA2/NeuroD1 in the Development of the Nervous SystemMolecular Neurobiology, 2004
- Extracellular-signal-regulated kinase signalling in neuronsCurrent Opinion in Neurobiology, 1999
- Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase KinaseJournal of Biological Chemistry, 1998
- μ-Opioid Receptor Internalization: Opiate Drugs Have Differential Effects on a Conserved Endocytic MechanismIn Vitroand in the Mammalian BrainPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,1998
- The Effect of Intrinsic Efficacy on Opioid Tolerance Anesthesiology, 1995
- Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cordJournal of Neuroscience, 1995
- U73122 inhibits phospholipase C-dependent calcium mobilization in neuronal cellsBrain Research, 1994
- A novel conformationally restricted protein kinase C inhibitor, Ro 31‐8425, inhibits human neutrophil superoxide generation by soluble, particulate and post‐receptor stimuliFEBS Letters, 1991